Huntington’s disease
-
Private Stock Sale Nets Half a Mil for Local Biopharma Company Battling Alzheimer’s, Parkinson’s
Berwyn-based QR Pharma, the biopharmaceutical company developing treatments for a number of neurological disorders, including Alzheimer’s and Parkinson’s diseases, has raised $530,000 in a private…
-
QR Pharma, Rockefeller University Research Drug For Huntington’s Disease
QR Pharma, Inc. of Berwyn is collaborating with The Rockefeller University to develop a treatment for Huntington’s disease. The collaboration will focus on preclinical research…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
